These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9436408)

  • 1. [Low-dose levodopa therapy of autistic disorder: evaluation of clinical effectiveness].
    Sugiyama N; Sugie H; Igarashi Y; Ito M; Fukuda T
    No To Hattatsu; 1998 Jan; 30(1):51-5. PubMed ID: 9436408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic changes in aromatic amino acids and monoamines in infantile autism and development of new treatment related to the finding].
    Naruse H; Hayashi T; Takesada M; Nakane A; Yamazaki K
    No To Hattatsu; 1989 Mar; 21(2):181-9. PubMed ID: 2653386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke. A double-blind placebo-controlled cross-over pilot study.
    Restemeyer C; Weiller C; Liepert J
    Restor Neurol Neurosci; 2007; 25(2):143-50. PubMed ID: 17726273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low dose L-dopa therapy and SST improved communication skill in a female autistic child].
    Arai S; Hoshino K
    No To Hattatsu; 2015 Jan; 47(1):55-6. PubMed ID: 25803914
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.
    King BH; Wright DM; Handen BL; Sikich L; Zimmerman AW; McMahon W; Cantwell E; Davanzo PA; Dourish CT; Dykens EM; Hooper SR; Jaselskis CA; Leventhal BL; Levitt J; Lord C; Lubetsky MJ; Myers SM; Ozonoff S; Shah BG; Snape M; Shernoff EW; Williamson K; Cook EH
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):658-65. PubMed ID: 11392343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic effects on encoding of a motor memory in chronic stroke.
    Floel A; Hummel F; Breitenstein C; Knecht S; Cohen LG
    Neurology; 2005 Aug; 65(3):472-4. PubMed ID: 16087920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Nutt JG
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16717244
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].
    Goulley F; Wolmark Y; Bourdeix I; Chaumet-Riffaud PD
    Therapie; 1993; 48(3):233-8. PubMed ID: 7908147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa improves procedural motor learning in chronic stroke patients.
    Rösser N; Heuschmann P; Wersching H; Breitenstein C; Knecht S; Flöel A
    Arch Phys Med Rehabil; 2008 Sep; 89(9):1633-41. PubMed ID: 18760148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
    Deleu D; Hanssens Y
    Neurology; 2006 May; 66(10):1611-2; author reply 1611-2. PubMed ID: 16721952
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopa-responsive dystonia (Segawa syndrome).
    Kamal N; Bhat DP; Carrick E
    Indian Pediatr; 2006 Jul; 43(7):635-8. PubMed ID: 16891685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers.
    Crevoisier C; Monreal A; Metzger B; Nilsen T
    Eur Neurol; 2003; 49(1):39-44. PubMed ID: 12464717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing dopaminergic therapy of Parkinson's disease.
    Horowski R
    Funct Neurol; 1988; 3(4):459-70. PubMed ID: 2907501
    [No Abstract]   [Full Text] [Related]  

  • 15. [Madopar in the complex therapy of ischemic insult].
    Odinak MM; Vozniuk IA; Kovalenko PA; Lobzin SV; Ianishevskiĭ SN
    Voen Med Zh; 2005 Jan; 326(1):35-9. PubMed ID: 15754768
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome.
    Nisijima K; Noguti M; Ishiguro T
    Biol Psychiatry; 1997 Apr; 41(8):913-4. PubMed ID: 9099421
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.
    Rezaei V; Mohammadi MR; Ghanizadeh A; Sahraian A; Tabrizi M; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1269-72. PubMed ID: 20637249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of secondary dystonia responding to levodopa.
    Bernard G; Vanasse M; Chouinard S
    J Child Neurol; 2010 Jun; 25(6):780-1. PubMed ID: 19808991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.
    Malone RP; Cater J; Sheikh RM; Choudhury MS; Delaney MA
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):887-94. PubMed ID: 11501687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A; Germanò E; Pustorino G; Impallomeni C; D'Arrigo C; Calamoneri F; Spina E
    J Child Adolesc Psychopharmacol; 2004; 14(1):39-47. PubMed ID: 15142390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.